Are you Dr. Srinivasan?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 39 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
22 Hill Rd
Parsippany, NJ 07054Phone+1 973-335-9909Fax+1 973-335-9910- Is this information wrong?
Summary
- Dr. Shankar Srinivasan, MD is a board certified psychiatrist in Parsippany, New Jersey. He is currently licensed to practice medicine in New Jersey, Louisiana, and Connecticut.
Education & Training
- Yale-New Haven Medical CenterFellowship, Child and Adolescent Psychiatry, 2005 - 2007
- Rutgers New Jersey Medical SchoolResidency, Psychiatry, 2002 - 2005
- University of the West Indies Faculty of MedicineClass of 2001
Certifications & Licensure
- NJ State Medical License 2006 - 2025
- LA State Medical License 2015 - 2024
- CT State Medical License 2005 - 2008
- American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- Efficacy Study of Inecalcitol With Decitabine in Acute Myeloid Leukemia Patients Unfit for Standard Chemotherapy Start of enrollment: 2016 Jun 01
Publications & Presentations
PubMed
- Darolutamide in Spanish patients with nonmetastatic castration-resistant prostate cancer: ARAMIS subgroup analysis.Joan Carles, Rafael A Medina-Lopez, Javier Puente, Álvaro Gómez-Ferrer, Javier Casas Nebra, María Isabel Sáez Medina, Maria J Ribal, Alfredo Rodríguez Antolín, José Lu...> ;Future Oncology. 2023 Apr 1
- 7 citationsEfficacy and Safety of Darolutamide in Patients with Nonmetastatic Castration-resistant Prostate Cancer Stratified by Prostate-specific Antigen Doubling Time: Planned ...Martin Bögemann, Neal D Shore, Matthew R Smith, Teuvo L J Tammela, Albertas Ulys, Egils Vjaters, Sergey Polyakov, Mindaugas Jievaltas, Murilo Luz, Boris Alekseev, Thie...> ;European Urology. 2023 Mar 1
- Efficacy and safety of darolutamide in Black/African-American patients from the phase III ARAMIS study.Neal D Shore, Felipe Cruz, Luke Nordquist, Laurence Belkoff, William J Aronson, Bhupendra Tolia, Arnold Cinman, Jorge Ortiz, Jacqueline Parkin, Shankar Srinivasan, Ton...> ;Future Oncology. 2022 Dec 1
- Join now to see all
Press Mentions
- Increasing Coverage, Decreasing Premiums Could Spearhead State Marketplace Platform ShiftAugust 18th, 2021